|
TGDS expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.729600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.329010E-01 |
| Normal-vs-Stage2 |
9.780500E-02 |
| Normal-vs-Stage3 |
4.940100E-02 |
| Normal-vs-Stage4 |
2.302000E-02 |
| Stage1-vs-Stage2 |
3.468200E-01 |
| Stage1-vs-Stage3 |
1.217780E-03 |
| Stage1-vs-Stage4 |
3.238200E-04 |
| Stage2-vs-Stage3 |
7.820300E-03 |
| Stage2-vs-Stage4 |
4.823800E-03 |
| Stage3-vs-Stage4 |
8.083800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.161000E-01 |
| Normal-vs-AfricanAmerican |
3.559000E-01 |
| Normal-vs-Asian |
2.631800E-01 |
| Caucasian-vs-AfricanAmerican |
3.168400E-01 |
| Caucasian-vs-Asian |
2.971000E-01 |
| AfricanAmerican-vs-Asian |
1.193420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.412400E-01 |
| Normal-vs-Female |
1.368580E-01 |
| Male-vs-Female |
2.169500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.117790E-01 |
| Normal-vs-Age(41-60Yrs) |
4.778200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.083400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.664000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.076400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.222990E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.270200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.933200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.048800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.072000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.475690E-02 |
| Normal-vs-Grade 2 |
3.409500E-02 |
| Normal-vs-Grade 3 |
3.848800E-01 |
| Normal-vs-Grade 4 |
2.398200E-04 |
| Grade 1-vs-Grade 2 |
2.745400E-01 |
| Grade 1-vs-Grade 3 |
4.930400E-02 |
| Grade 1-vs-Grade 4 |
2.634200E-04 |
| Grade 2-vs-Grade 3 |
3.035900E-03 |
| Grade 2-vs-Grade 4 |
8.41089999870093E-08 |
| Grade 3-vs-Grade 4 |
4.538300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.53090000000389E-05 |
| Normal-vs-ccB subtype |
1.321060E-03 |
| ccA subtype-vs-ccB subtype |
2.5042190543445E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.381800E-01 |
| Normal-vs-N1 |
3.381900E-02 |
| N0-vs-N1 |
4.595600E-02 |
|
|
